EXACT Accumulated Other Comprehensive Income from 2010 to 2024
| EXAS Stock | USD 54.00 1.59 2.86% |
Accumulated Other Comprehensive Income | First Reported 2001-03-31 | Previous Quarter 1.4 M | Current Value -499 K | Quarterly Volatility 2.3 M |
Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT main balance sheet or income statement drivers, such as Interest Expense of 25.6 M, Other Operating Expenses of 2.8 B or Research Development of 447.2 M, as well as many exotic indicators such as Price To Sales Ratio of 5.06, Dividend Yield of 0.0 or PTB Ratio of 4.47. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.
EXACT | Accumulated Other Comprehensive Income |
Latest EXACT Sciences' Accumulated Other Comprehensive Income Growth Pattern
Below is the plot of the Accumulated Other Comprehensive Income of EXACT Sciences over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. EXACT Sciences' Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EXACT Sciences' overall financial position and show how it may be relating to other accounts over time.
| Accumulated Other Comprehensive Income | 10 Years Trend |
|
Accumulated Other Comprehensive Income |
| Timeline |
EXACT Accumulated Other Comprehensive Income Regression Statistics
| Arithmetic Mean | (462,533) | |
| Geometric Mean | 412,612 | |
| Coefficient Of Variation | (338.33) | |
| Mean Deviation | 960,231 | |
| Median | (115,000) | |
| Standard Deviation | 1,564,905 | |
| Sample Variance | 2.4T | |
| Range | 6.7M | |
| R-Value | (0.08) | |
| Mean Square Error | 2.6T | |
| R-Squared | 0.01 | |
| Significance | 0.79 | |
| Slope | (26,662) | |
| Total Sum of Squares | 34.3T |
EXACT Accumulated Other Comprehensive Income History
About EXACT Sciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include EXACT Sciences income statement, its balance sheet, and the statement of cash flows. EXACT Sciences investors use historical funamental indicators, such as EXACT Sciences's Accumulated Other Comprehensive Income, to determine how well the company is positioned to perform in the future. Although EXACT Sciences investors may use each financial statement separately, they are all related. The changes in EXACT Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on EXACT Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on EXACT Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in EXACT Sciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.4 M | 1.5 M |
Pair Trading with EXACT Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EXACT Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXACT Sciences will appreciate offsetting losses from the drop in the long position's value.Moving against EXACT Stock
| 0.47 | DRIO | DarioHealth Corp Earnings Call Today | PairCorr |
| 0.44 | MDXH | MDxHealth SA ADR Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to EXACT Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EXACT Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EXACT Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EXACT Sciences to buy it.
The correlation of EXACT Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EXACT Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EXACT Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EXACT Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of EXACT Sciences Correlation against competitors. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for EXACT Stock analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.31) | Revenue Per Share 13.998 | Quarterly Revenue Growth 0.058 | Return On Assets (0.03) | Return On Equity (0.08) |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.